2020
Gage SM, Reichert H . 2020. Determining the incidence of needle-related complications in hemodialysis access: We need a better system. J Vasc Access 22(4):521-532; doi: 10.1177/1129729820946917 . PMID: 32811335.
View Abstract
Publication: Manuscripts
/ Topics: Epidemiology , Health Economics and Outcomes Research (HEOR)
Elbeddini A, Hooda N , Gazarin M, Webster P, McMillan J. 2020. Irinotecan-associated dysarthria in patients with pancreatic cancer: A single site experience. Am J Case Rep 21:e924058; doi: 10.12659/AJCR.924058 . PMID: 32594093.
View Abstract
Publication: Manuscripts
/ Topics: Cancer , drug interactions , pharmacology
Dean R, Arjunji R, Awano H, Igarash A, Tanaka A, Jensen IS , Cyr PL et al. Cost-effectiveness of onasemnogene abeparvocec (ZOLGENSMA) for spinal muscular atrophy type 1 against nusinersen in Japan. ISPOR 25th Annual International Meeting, Orlando FL, 2020.
Publication: Abstracts and Presentations
/ Topics: Epidemiology , Health Economics and Outcomes Research (HEOR)
Sacks NC , Healey B, Cyr PL , Graham R. Economic burden of X-linked myotubular myopathy (XLMTM) by ventilation status. ISPOR 25th Annual International Meeting, Orlando FL, 2020.
Publication: Abstracts and Presentations
/ Topics: Epidemiology , Health Economics and Outcomes Research (HEOR)
Miller B, Jensen IS , Dean R, Cyr PL , Slocomb T, James E, Beggs AH. Health resource use in patients with x-linked myotubular myopathy (XLMTM): Data from the RECENSUS Study. ISPOR 25th Annual International Meeting, Orlando FL, 2020.
Publication: Abstracts and Presentations
/ Topics: Epidemiology
Miller B, Yao W, Dean R, Jensen I , Cyr PL , Slocomb T. Understanding the impact of XLMTM on parents and caregivers in the US: An analysis of survey results. ISPOR 18th Annual European Meeting, Milan Italy, 2020.
Publication: Abstracts and Presentations
/ Topics: Epidemiology
Hathway J, Miller-Wilson L, Jensen I , Ozbay B, Regan C, Jena A, et al. 2020. Projecting total costs and health consequences of increasing mt-sDNA utilization for colorectal cancer screening from the payer and integrated delivery network perspectives. J Med Econ 23(6):581-592; doi: 10.1080/13696998.2020.1730123 . PMID: 32063100.
View Abstract